Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Nat Nanotechnol. 2022 Feb;17(2):206-216. doi: 10.1038/s41565-021-01032-w. Epub 2021 Dec 16.
Nat Nanotechnol. 2022.
PMID: 34916656
Free PMC article.